What is the address of NEPEMEDIC?

The registered office of NEPEMEDIC is located at Chemin de l'Herbe, Bonlez 19, 1325 Chaumont-Gistoux.

Is NEPEMEDIC still active?

Yes. According to the CBE (30 October 2026) NEPEMEDIC is active, legal situation “Normale toestand”, started on 22 June 2000.

Is NEPEMEDIC registered on Peppol?

Yes, NEPEMEDIC is registered on the Peppol network with ID 0208:0472173036.

What is the enterprise number of NEPEMEDIC?

The enterprise number of NEPEMEDIC is BE0472173036.

When was NEPEMEDIC founded?

NEPEMEDIC was founded on 22 June 2000.

Who are the directors of NEPEMEDIC?

According to the 2025 annual accounts, the directors of NEPEMEDIC are: Brigitte HENROT.

Is NEPEMEDIC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 June 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NEPEMEDIC make in 2025?

NEPEMEDIC posted a profit after taxes of € 45,901 in financial year 2025.

What is the revenue of NEPEMEDIC?

As a small company, NEPEMEDIC is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 71,238.

NEPEMEDIC (Private Limited) - Chaumont-Gistoux

Dossier NEPEMEDIC, printed on 30 October 2026 from databakkes.be/en/0472173036/nepemedic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 51 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

NEPEMEDIC from Chaumont-Gistoux, company number BE0472173036, closed financial year 2025 with a result of € 45,901 after tax. For that financial year NEPEMEDIC recorded a gross margin of € 71,238 and equity of € 308,406. Compared with financial year 2024, the result moved from € 15,720 to € 45,901. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.

What it is worth Growing

€ 308,406

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 45,901

▲ 192% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4,190

▲ € 4,121 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

2 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 71,210 Gross margin 2022: € 71,210 First fiscal year in the series	€ 51,741 Gross margin 2023: € 51,741 ▼ 27% vs 2022 (€ 71,210) Unfavourable step	€ 34,488 Gross margin 2024: € 34,488 ▼ 33% vs 2023 (€ 51,741) Unfavourable step	€ 71,238 Gross margin 2025: € 71,238 ▲ 107% vs 2024 (€ 34,488) Favourable step	▲ 107%
Profit after taxes	€ 40,177 Profit after taxes 2022: € 40,177 First fiscal year in the series	€ 27,415 Profit after taxes 2023: € 27,415 ▼ 32% vs 2022 (€ 40,177) Unfavourable step	€ 15,720 Profit after taxes 2024: € 15,720 ▼ 43% vs 2023 (€ 27,415) Unfavourable step	€ 45,901 Profit after taxes 2025: € 45,901 ▲ 192% vs 2024 (€ 15,720) Favourable step	▲ 192%
Equity	€ 342,481 Equity 2022: € 342,481 First fiscal year in the series	€ 369,095 Equity 2023: € 369,095 ▲ 8% vs 2022 (€ 342,481) Favourable step	€ 263,338 Equity 2024: € 263,338 ▼ 29% vs 2023 (€ 369,095) Unfavourable step	€ 308,406 Equity 2025: € 308,406 ▲ 17% vs 2024 (€ 263,338) Favourable step	▲ 17%
Total debts	€ 82,332 Total debts 2022: € 82,332 First fiscal year in the series	€ 57,425 Total debts 2023: € 57,425 ▼ 30% vs 2022 (€ 82,332) Favourable step	€ 82,170 Total debts 2024: € 82,170 ▲ 43% vs 2023 (€ 57,425) Unfavourable step	€ 32,449 Total debts 2025: € 32,449 ▼ 61% vs 2024 (€ 82,170) Favourable step	▼ 61%
Cash	€ 7,520 Cash 2022: € 7,520 First fiscal year in the series	€ 3,501 Cash 2023: € 3,501 ▼ 53% vs 2022 (€ 7,520) Unfavourable step	€ 70 Cash 2024: € 70 ▼ 98% vs 2023 (€ 3,501) Unfavourable step	€ 4,190 Cash 2025: € 4,190 ▲ € 4,121 vs 2024 (€ 70) Favourable step	▲ € 4,121
Land & buildings	€ 335,130 Land & buildings 2022: € 335,130 First fiscal year in the series	€ 328,547 Land & buildings 2023: € 328,547 ▼ 2% vs 2022 (€ 335,130) Unchanged	€ 323,000 Land & buildings 2024: € 323,000 ▼ 2% vs 2023 (€ 328,547) Unchanged	€ 325,424 Land & buildings 2025: € 325,424 ▲ 1% vs 2024 (€ 323,000) Unchanged	▲ 1%
Retained profit	€ 209,436 Retained profit 2022: € 209,436 First fiscal year in the series	€ 236,051 Retained profit 2023: € 236,051 ▲ 13% vs 2022 (€ 209,436) Favourable step	€ 250,938 Retained profit 2024: € 250,938 ▲ 6% vs 2023 (€ 236,051) Favourable step	€ 296,006 Retained profit 2025: € 296,006 ▲ 18% vs 2024 (€ 250,938) Favourable step	▲ 18%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 833 Dividend 2024: € 833 ▲ 4% vs 2023 (€ 800) Unchanged	€ 833 Dividend 2025: € 833 Unchanged (€ 833) Unchanged
Bank debt	€ 51,946 Bank debt 2022: € 51,946 First fiscal year in the series	€ 39,141 Bank debt 2023: € 39,141 ▼ 25% vs 2022 (€ 51,946) Favourable step	€ 16,966 Bank debt 2024: € 16,966 ▼ 57% vs 2023 (€ 39,141) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 16,966) Favourable step	▼ 100%
Balance sheet total	€ 424,813 Balance sheet total 2022: € 424,813 First fiscal year in the series	€ 426,520 Balance sheet total 2023: € 426,520 Unchanged (€ 424,813) Unchanged	€ 345,508 Balance sheet total 2024: € 345,508 ▼ 19% vs 2023 (€ 426,520) Unchanged	€ 346,355 Balance sheet total 2025: € 346,355 Unchanged (€ 345,508) Unchanged

Key figures of NEPEMEDIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NEPEMEDIC?

What happened at NEPEMEDIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 5, 2026 New annual accounts for financial year 2025: profit of € 45,901 (▲ 192% vs 2024). Source: NBB ↗
Jul 1, 2000 New establishment in Chaumont-Gistoux. KBO
Jun 22, 2000 Start of the company according to the CBE. KBO
2000 Brigitte HENROT became a director. NBB

In short

From € 40,177 profit in 2022 to € 45,901 profit in 2025.

Paid € 51,651 in corporate taxes since 2022.

Best year ever: 2025, with € 45,901 profit.

Paid out € 3,266 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Brigitte HENROT

NEPEMEDIC

Behind NEPEMEDIC is Brigitte HENROT.

Directors

According to the 2025 annual accounts

Brigitte HENROT

Director

since 2000

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin de l'Herbe, Bonlez 19

1325 Chaumont-Gistoux

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0472.173.036
VAT number: BE 0472.173.036
Registered office: Chemin de l'Herbe, Bonlez 19, 1325 Chaumont-Gistoux
Names & denominations: NEPEMEDIC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 June 2000
Peppol: Active · Active since 22 Apr 2026

View on CBE Public ↗ Annual accounts (NBB) ↗